"

According to the latest report published by Data Bridge Market Research, the Next-Generation Sequencing (NGS) Services Market

 CAGR Value

As per Data Bridge Market Research Analysis the global next-generation sequencing (NGS) services market size was valued at USD 14.57 billion in 2025 and is expected to reach USD 71.51 billion by 2033, at a CAGR of 22.00% during the forecast period

Next-Generation Sequencing (NGS) Services Market is the world-class market research report which carries out industry analysis for Next-Generation Sequencing (NGS) Services Market industry on products, markets, companies, industries and most of the countries worldwide. This market report is a great source of notable data, present market trends, future events, market environment, technological innovation, imminent technologies and the technical development in the Next-Generation Sequencing (NGS) Services Market industry. The collected information and data is tested and verified by the market experts before offering it to the end user. Next-Generation Sequencing (NGS) Services Market research analysis and data lend a hand to businesses for the planning of strategies related to investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-ngs-services-market

Next-Generation Sequencing (NGS) Services Market Segmentation and Market Companies

Segments

- Based on Service Type, the global Next-Generation Sequencing (NGS) Services market is segmented into Targeted Resequencing, RNA sequencing, De Novo Sequencing, Exome Sequencing, Chip Sequencing, Methyl Sequencing, and others. The RNA sequencing segment is expected to witness significant growth due to the increasing application of transcriptomics in disease diagnosis, drug discovery, and personalized medicine.

- By Application, the market is divided into Oncology, Clinical Investigation, Reproductive Health, Evolutionary Biology, Agrigenomics, and others. The oncology segment dominates the market as NGS services are extensively used in cancer research to identify genetic mutations responsible for the development and progression of cancer.

- On the basis of End-User, the market is categorized into Academic & Clinical Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Contract Research Organizations (CROs). The pharmaceutical and biotechnology companies segment holds the largest market share as these organizations heavily invest in NGS services to develop precision medicine and innovative therapies.

Market Players

- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Eurofins Scientific
- BGI
- PerkinElmer Inc.
- Macrogen, Inc.
- GENEWIZ
- GATC Biotech AG
- DNA Link, Inc.

The global NGS services market is highly competitive with the presence of several key players. Illumina, Inc. holds a dominant position due to its wide product portfolio and strategic collaborations with research institutes and pharmaceutical companies. Thermo Fisher Scientific Inc. is another major player known for its advanced NGS platforms and strong distribution network. Qiagen and Eurofins Scientific are also significant participants in the market, offering end-to-end NGS solutions to cater to the diverse needs of customers. Emerging players like BGI and GENEWIZ are focusing on expanding their service offerings and geographical presence to gain a competitive edge in the market.

The Next-Generation Sequencing (NGS) Services market is witnessing significant growth driven by technological advancements, increasing research activities in genomics, and rising demand for personalized medicine. As the healthcare industry transitions towards precision medicine, the demand for NGS services is expected to surge further. RNA sequencing is emerging as a key segment within the market due to its wide applications in disease diagnosis, drug discovery, and personalized medicine. This segment is likely to witness substantial growth as transcriptomics gains importance in understanding disease mechanisms at a molecular level.

The oncology segment remains a dominant application area for NGS services, particularly in cancer research. With the high prevalence of cancer worldwide and the urgent need for better treatment options, NGS services play a crucial role in identifying genetic mutations and biomarkers associated with different types of cancer. This trend is expected to continue, driving the growth of the NGS services market in the oncology segment.

In terms of end-users, pharmaceutical and biotechnology companies are the major contributors to the NGS services market. These organizations heavily invest in NGS services to accelerate precision medicine initiatives, develop innovative therapies, and enhance drug discovery processes. Academic and clinical research institutes also play a significant role in driving market growth by conducting extensive genomic research and collaborating with industry players to translate research findings into clinical applications.

Among the key market players, Illumina, Inc. stands out as a dominant player with its diversified product portfolio and strategic collaborations. The company's strong presence in the NGS market is bolstered by its focus on innovation and partnerships with research institutions and pharmaceutical companies. Thermo Fisher Scientific Inc. is another notable player known for its advanced NGS technologies and robust distribution network, enabling it to cater to a global customer base effectively.

Qiagen and Eurofins Scientific are also key players offering comprehensive NGS solutions to meet the evolving needs of customers across different industries. These players are investing in R&D activities to introduce new services and technologies to stay competitive in the dynamic NGS services market. Additionally, emerging players like BGI and GENEWIZ are expanding their service offerings and geographical reach to capitalize on growth opportunities in the market.

Overall, the global NGS services market is poised for substantial growth driven by technological advancements, increasing adoption of NGS in diverse applications, and the expanding collaborations between industry players and research institutions. As precision medicine gains traction, the demand for NGS services is expected to escalate, creating lucrative opportunities for market players to innovate and differentiate their offerings to meet the evolving needs of customers.The Next-Generation Sequencing (NGS) Services market is a thriving industry driven by advancements in technology, increased focus on genomics research, and the growing demand for personalized medicine. One of the key trends shaping the market is the rising popularity of RNA sequencing services. This segment is witnessing significant growth due to its diverse applications in disease diagnosis, drug discovery, and personalized medicine. As transcriptomics becomes increasingly crucial in understanding disease mechanisms at a molecular level, the demand for RNA sequencing services is expected to continue to surge.

In the realm of applications, oncology stands out as a dominant segment in the NGS services market. The prevalence of cancer globally and the need for effective treatment options have propelled the use of NGS services in cancer research. Identifying genetic mutations and biomarkers associated with various types of cancer is critical for improving diagnostics and treatment outcomes. Hence, the oncology segment is anticipated to maintain its prominence in driving the growth of the NGS services market.

Within the end-user category, pharmaceutical and biotechnology companies are major contributors to the market. These entities are heavily investing in NGS services to advance precision medicine initiatives, develop innovative therapies, and enhance drug discovery processes. Concurrently, academic and clinical research institutes play a pivotal role in propelling market growth by conducting extensive genomic research and collaborating with industry stakeholders to translate research findings into practical applications.

Notably, Illumina, Inc. emerges as a dominant player in the NGS services market, leveraging a diversified product portfolio and strategic partnerships with research institutions and pharmaceutical firms. Thermo Fisher Scientific Inc. also commands a significant presence with its cutting-edge NGS technologies and robust distribution network catering to a global clientele. Players like Qiagen and Eurofins Scientific are actively offering comprehensive NGS solutions to meet the evolving demands of customers across various sectors. These companies continue to invest in R&D efforts to introduce novel services and technologies to maintain their competitiveness in the dynamic NGS services landscape. Additionally, emerging players such as BGI and GENEWIZ are expanding their service offerings and geographical footprint to leverage growth prospects in the market.

In conclusion, the global NGS services market is primed for substantial expansion fueled by technological innovations, increasing adoption of NGS in diverse applications, and the burgeoning collaborations between industry participants and research institutions. As precision medicine gains traction, the demand for NGS services is expected to escalate, presenting lucrative opportunities for market players to innovate and tailor their offerings to meet the evolving needs of customers effectively.

Frequently Asked Questions About This Report

What are the technical limitations hindering Next-Generation Sequencing (NGS) Services Market expansion?
What is the impact of e-procurement on Next-Generation Sequencing (NGS) Services Market efficiency?
How are smart Next-Generation Sequencing (NGS) Services Market solutions gaining traction?
How is the shift toward sustainability driving Next-Generation Sequencing (NGS) Services Market trends?
How do import/export policies impact the Next-Generation Sequencing (NGS) Services Market?
How are smart Next-Generation Sequencing (NGS) Services Market solutions gaining traction?
What are the top 5 companies by revenue in the Next-Generation Sequencing (NGS) Services Market?
How much is the Next-Generation Sequencing (NGS) Services Market expected to grow in absolute dollar terms by 2033?
What is the market top position o in the Next-Generation Sequencing (NGS) Services Market industry?
How does currency fluctuation affect the global Next-Generation Sequencing (NGS) Services Market?
What is the impact of Mass Migration on Next-Generation Sequencing (NGS) Services Market demand?
How is Just-in-Time manufacturing affecting the Next-Generation Sequencing (NGS) Services Market?

Browse More Reports:

U.A.E. Kraft Paper Market
Global Methenamine Hippurate Tablets Market
Global Flavored Spirits Market
Global Vitamin C Market
Global Circulating Tumor DNA (ctDNA) Market
Asia-Pacific Ophthalmology Market
Global Analytics Market
Asia-Pacific Deodorant Market
Global Label Printing Market
Global Unmanned Aerial Vehicle Market
Global Industrial Rubber Market
Global Mental Illnesses Market
Global Optical Fiber Components Market
Global Lysine Market
Global Geotextile Market

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 1010
Email:- corporatesales@databridgemarketresearch.com"